Healthcare and diagnostics companies are drawing growing investor interest in the primary market. Recent filings indicate multiple firms from fertility, diagnostics and hospital segments are evaluating IPO plans.
The sector’s structural growth visibility and rising healthcare spending are supporting sentiment. Analysts believe defensive business models are appealing in the current volatile environment.
However, valuation comfort and execution track record will remain key for strong subscription.
